Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel diazotization route for 1-hydroxycyclopropanecarboxylic acid offers higher yields and safer scale-up for pharmaceutical intermediates.
Patent CN109053528A reveals a safer Levetiracetam route avoiding toxic reagents. This enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN102260272B details high-purity Irinotecan synthesis. Eliminates pyridine, improves yield, ensures supply chain reliability for pharmaceutical manufacturers globally.
Novel patent CN116621742B route for oxopyridine compounds. Enhances selectivity and yield for pharmaceutical intermediates. Reliable supply chain partner.
Novel Pd-catalyzed synthesis avoids toxic CO gas usage. High yield 77%. Reliable supply chain for sulfur-containing heterocycles and pharmaceutical intermediates manufacturing.
Patent CN116925093A details a refined irinotecan synthesis using 1-methylpyrrolidine. This method offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN112624921A reveals a novel Grignard-based synthesis for 1-hydroxymethyl cyclopropyl acetic acid, offering significant cost reduction and safety improvements for Montelukast manufacturing.
Patent CN102304007B reveals high-ee asymmetric hydrogenation using chiral Ru catalysts enabling cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Patent CN107460497A enables cost-effective electrochemical Minisci acylation. Eliminate silver catalysts for scalable pharmaceutical intermediate manufacturing.
Novel ethanol and THF crystallization method for Prucalopride achieving over 99.8 percent purity. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN104030970A details a mild gold-catalyzed route for functionalized carbazoles. Enhances purity and supply chain reliability for pharmaceutical and material science applications.
Patent CN115448912B reveals high-purity posaconazole intermediate synthesis. Enzymatic route offers supply chain stability and cost reduction in API manufacturing.
Patent CN113912562A reveals a green, catalyst-free route for oxazepine derivatives, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel metal-free synthesis of isatin exocyclic diene intermediates offering high selectivity and supply chain reliability for pharmaceutical manufacturing.
Patent CN105732568A offers safer chiral intermediate synthesis. Reduces toxic reagents and improves scalability for pharmaceutical manufacturing supply chains globally.
Patent CN108440550B reveals a novel FePc-catalyzed synthesis. Offers high purity pharmaceutical intermediates with scalable cost reduction and supply chain reliability for global buyers.
Novel route for Tivozanib via Friedel-Crafts and cyclization. High yield, low cost. Ideal for reliable tivozanib intermediate supplier partnerships.
Novel chemical route for Lycibarbarine A and B using D-2-deoxyribose. Significantly reduces synthesis steps and enhances scalability for antidepressant drug development.
Novel regioselective acylation method improves yield and purity for temsirolimus production, offering supply chain stability and cost efficiency for global buyers.
Novel TEMPO-mediated hydroxylation patent CN107686460A offers cost-effective pharmaceutical intermediate manufacturing with scalable room temperature processes.